XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 66 $ 34,769,076 $ (38,322,456) $ (153,254) $ (3,706,568)
Beginning balance, shares at Dec. 31, 2020 6,583,924 257        
Common Stock Offering for Cash $ 8   2,661,992     2,662,000
Common Stock Offering for Cash, shares 757,655          
Costs of Capital     (2,091,101)     (2,091,101)
Stock Based Compensation     801,908     801,908
Common Stock for Accounts Payable $ 1   99,789     99,789
Common stock for accounts payable, shares 27,896          
Common Stock for Costs of Financing $ 6   1,932,730     1,932,736
Common stock for costs of Financing, shares 628,750          
Warrants for Services     148,480     148,480
Warrants for Interest Expense     69,729     69,729
Convertible Debenture Value     69,729     69,729
Preferred Stock - Series B for Dividend     23,750     23,750
Preferred Stock - Series B for Dividend, shares   2        
Preferred Stock - Series B Shares and Dividend Payable to Common Stock $ 11   432,165     432,176
Preferred Stock - Series B Shares and Dividend Payable to Common Stock, shares 1,090,015 (259)        
Dividends - P/S Series B       (40,301)   (40,301)
Conversion of Debt & Interest to Common Stock $ 4   1,294,576     1,294,580
Conversion of Debt & Interest to Common Stock, shares 439,527          
Exercise of options and warrants $ 1   514,696     $ 514,697
Exercise of options and warrants, shares 140,602         62,500
Net Loss   (2,998,644)   $ (2,998,644)
Comprehensive Loss         9,761 9,761
Ending balance, value at Dec. 31, 2021 $ 97 40,727,518 (41,361,401) (143,493) (777,279)
Ending balance, shares at Dec. 31, 2021 9,668,369 0        
Common Stock Offering for Cash $ 19   8,011,231     8,011,250
Common Stock Offering for Cash, shares 1,885,000          
Costs of Capital     (1,105,142)     (1,105,142)
Stock Based Compensation     67,500     67,500
Exercise of options and warrants   23,000     23,000
Exercise of options and warrants, shares 8,214          
Net Loss   (666,798)   (666,798)
Comprehensive Loss         (25,290) (25,290)
Common Stock issued for conversion error      
Common Stock issued for conversion error, shares 64          
Subscription Receivable     (7,370,350)      
Ending balance, value at Mar. 31, 2022 $ 116 $ 40,353,757 $ (42,028,199) $ (168,783) $ (1,843,109)
Ending balance, shares at Mar. 31, 2022 11,561,647 0